Last month, Grupo Galilea had the privilege of participating in the II Conference of the platforms of the Institute of Health Carlos III (ISCIII), a key meeting for the advancement of research, development and innovation (R+D+I) in biomedicine and health sciences. This event, held in Lleida, brought together leading professionals and organizations in the sector, creating a space for exchange and collaboration that is essential for the future of biomedical research.
Linkage with R&D&I through the clinical trials department.
From its experience in insurance, Grupo Galilea maintains an active commitment to innovation in health, a commitment that is materialized in its clinical trials department. This department plays an essential role in connecting Grupo Galilea with the world of biomedical research, allowing us to contribute to projects and developments that impact the welfare of society.
During this conference, the Galilea Group team had the opportunity to learn about the latest advances in biomedicine and to strengthen strategic alliances with researchers and experts in the sector. This participation strengthens our mission to offer insurance solutions that respond to emerging healthcare needs, while promoting innovation as an essential pillar for the future of healthcare.
Visit our clinical trials website
As part of our commitment, we have developed a website specialized in clinical trials, where we share updated and relevant information about our activities in the biomedical sector. We invite you to discover how we work in the development of new treatments and solutions for the well-being of all, visit us and learn more about our contributions to health!
Click here to visit the website.
Source: Galilea Group
